Also known as آسٹیوپوروسس مینجمنٹ
Family Physician
M.R.C.P, M.B.B.S.
Endocrinologist
M.B.B.S., F.C.P.S. (Endocrinologist), F.C.P.S. (Medicine)
Diabetologist
American Diabetologist, MBBS (Pb), DABM (USA), DABN (USA), FACP (USA), Diplomate American Board Of Internal Medicine & Diabetes (USA), Diplomate American Board Of Nephrology & Hypertension (USA), Fellow Of American College Of Physicians, FACP (USA), Obesit
Diabetologist
American Diabetologist, MBBS (Pb), DABM (USA), DABN (USA), FACP (USA), Diplomate American Board Of Internal Medicine & Diabetes (USA), Diplomate American Board Of Nephrology & Hypertension (USA), Fellow Of American College Of Physicians, FACP (USA), Obesit
Internal Medicine Specialist
M.B.B.S., F.C.P.S., M.R.C.P, F.R.C.P.
Gastroenterologist
F.C.P.S., M.B.B.S.
Internal Medicine Specialist
MBBS, M.D., M.C.P.S, M.P.H.
Gastroenterologist
MBBS, MD (Gastroenterology), Fellowship in ERCP
Family Physician
MBBS, MCPS (Family Medicine)
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures